Denmark's economic growth, which economists say is due to an "exceptional surge" in pharmaceutical exports, is expected to weaken this year — but the looming threat of U.S. tariffs on the pharma ...
Denmark’s final quarterly GDP growth accelerated sharply to 2.2% from 1.3% previously, a gain of 0.9 percentage points and roughly a 69% increase in the growth rate. The data confirm solid momentum in ...
Novo Nordisk, Denmark’s fat jab pharmaceutical giant, reached an unwelcome milestone last week. After a dizzying 76pc plunge in its share price over the past 18 months, a torrid ...